HOME ABOUT US SERVICES RESEARCH EQUITY DERIVATIVES IPO INTERNET TRADING FTP CONTACT US
  
SENSEX 461.30 1.99%
23622.90
 
NIFTY 1695.40 2.30%
75527.95
 
Nasdaq 79.18 0.31%
25888.84
 
Nikkei 225 1802.77 2.81%
66020.04
 
FTSE 100 167.80 1.63%
10471.70
 
YOU ARE ON
Equity
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
 
Aptus Pharma Ltd.
 
Source DateBoard Meeting DateDetails
09-Jun-2026 12-Jun-2026 Preferential Issue of shares Inter alia, to consider and deliberate upon the following proposed agenda item:- I. To consider, evaluate and deliberate upon the proposal for raising of funds through: (a) issuance of equity shares and / or any other eligible securiOes by way of PreferenOal Allotment, in accordance with the provisions of the SecuriOes and Exchange Board of India (Issue of Capital and Disclosure Requirements) RegulaOons, 2018, as amended ("SEBI ICDR RegulaOons"), the Companies Act, 2013 and rules framed thereunder, and other applicable laws and regulaOons, subject to such approvals, permissions and sancOons of the shareholders of the Company and / or regulatory and statutory authoriOes as may be required; and (b) Borrowings from banks / financial insOtuOons / other lenders. II. To consider and, if thought fit, to authorize the Managing Director of the Company to (a) idenOfy, evaluate and interact with prospecOve investor(s) / proposed allo?ee(s) in connecOon with the aforesaid proposed preferenOal allotment, and to finalize and place before the Board of Directors, at a subsequent meeOng, the list of proposed allottee(s) along with all requisite details as prescribed under the SEBI ICDR Regulations and the Companies Act, 2013, for consideraOon and approval of the Board. (b) idenOfy and approach prospecOve lenders for the borrowing requirements at the best available terms ? and to report back to the Board.
20-Apr-2026 27-Apr-2026 Audited Results
17-Mar-2026 24-Mar-2026 Bonus issue & Increase in Authorised Capital Inter alia, to consider a proposal for:- 1. Increase in Authorized Share Capital subject to approval of members of the Company. 2. Consideration and recommendation of Bonus Equity Shares subject to approval of Members of the Company.
03-Nov-2025 10-Nov-2025 Half Yearly Results
Page 1 of 1
Prev || Next
 
ADINATH STOCK BROKING PVT LTD  :   SEBI REGISTRATION NUMBERS : Bombay Stock Exchange(BSE): CASH -INZ000204337 & DERIVATIVE -INZ000204337 Member ID-3175 National Stock Exchange(NSE): CASH- INZ000204337 & DERIVATIVES -INZ000204337 Member ID-12805 MCX-SX Stock Exchange(MCX-SX): Currency Derivative : INZ000204337 Member ID-44400 United Stock Exchange(USE): Currency Derivative: Central Depository Services Ltd(CDSL)- IN -DP-452/2008 DP ID 12055200
ATTENTION INVESTORS :   "Prevent unauthorised transactions in your Broking & demat account--> Update your mobile numbers/email IDs with your stock brokers & depository participate. Receive information of your transactions directly from Exchange & CDSL on your mobile/email at the end of the day......................Issued in the interest of Investors"
ATTENTION INVESTORS :   "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
ATTENTION INVESTORS :   "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
ATTENTION INVESTORS :   1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. "Issued in the interest of Investors"
| Disclaimer | Privacy Policy | Feedback | Terms and Conditions | Careers | Investor Grievances | Download | Investor Protection | SCORES | Site Map
Investor Charter - DP | Investor Charter - Stock Broker | e-voting | Investor Education | Client Collateral Details | NSDL eVoting | Advisory for investors
Useful links: NSE | BSE | MCX-SX | CDSL | SEBI | MCX | NCDEX | FMC | Smart ODR
SEBI Registration No.INZ000042629
Copyright © 2011 Adinath Stock Broking Pvt Ltd                             Designed, Developed & Content Powered By ●●● Accord Fintech Pvt.Ltd.